CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C03304 | BRD-K02788568 | BRD-K02788568 | -- | -- | -- | Details |
| C03305 | BRD-K02793474 | BRD-K02793474 | -- | -- | -- | Details |
| C03306 | BRD-K02796109 | BRD-K02796109 | -- | -- | -- | Details |
| C03307 | BRD-K02802091 | BRD-K02802091 | -- | -- | -- | Details |
| C03308 | BRD-K02806746 | BRD-K02806746 | -- | -- | -- | Details |
| C03309 | BRD-K02809100 | BRD-K02809100 | -- | -- | -- | Details |
| C03310 | BRD-K02811477 | BRD-K02811477 | -- | -- | -- | Details |
| C03311 | BRD-K02813113 | BRD-K02813113 | -- | -- | -- | Details |
| C03312 | BRD-K02817669 | BRD-K02817669 | -- | -- | -- | Details |
| C03313 | BRD-K02822062 | CT-200783 | -- | -- | -- | Details |
| C03314 | BRD-K02823077 | BRD-K02823077 | -- | -- | -- | Details |
| C03315 | BRD-K02827191 | BRD-K02827191 | -- | -- | -- | Details |
| C03316 | BRD-K02833343 | BRD-K02833343 | -- | -- | -- | Details |
| C03317 | BRD-K02834582 | SM-406 | -- | -- | -- | Details |
| C03318 | BRD-K02837259 | BRD-K02837259 | -- | -- | -- | Details |
| C03319 | BRD-K02839126 | BRD-K02839126 | -- | -- | -- | Details |
| C03320 | BRD-K02844551 | BRD-K02844551 | -- | -- | -- | Details |
| C03321 | BRD-K02847640 | BRD-K02847640 | -- | -- | -- | Details |
| C03322 | BRD-K02861439 | BRD-K02861439 | -- | -- | -- | Details |
| C03323 | BRD-K02862004 | BRD-K02862004 | -- | -- | -- | Details |
| C03324 | BRD-K02866760 | BRD-K02866760 | -- | -- | -- | Details |
| C03325 | BRD-K02867583 | minaprine | HTR2B; SLC6A4 | Serotonin reuptake inhibitor | -- | Details |
| C03326 | BRD-K02876750 | BRD-K02876750 | -- | -- | -- | Details |
| C03327 | BRD-K02881560 | BRD-K02881560 | -- | -- | -- | Details |
| C03328 | BRD-K02882069 | BRD-K02882069 | -- | -- | -- | Details |
| C03329 | BRD-K02882086 | BRD-K02882086 | -- | -- | -- | Details |
| C03330 | BRD-K02885102 | BRD-K02885102 | -- | -- | -- | Details |
| C03331 | BRD-K02897131 | BRD-K02897131 | -- | -- | -- | Details |
| C03332 | BRD-K02898090 | kifunensine | -- | -- | -- | Details |
| C03333 | BRD-K02900412 | clofoctol | -- | -- | -- | Details |
| C03334 | BRD-K02914492 | BRD-K02914492 | -- | -- | -- | Details |
| C03335 | BRD-K02917242 | BRD-K02917242 | -- | -- | -- | Details |
| C03336 | BRD-K02920459 | BRD-K02920459 | -- | -- | -- | Details |
| C03337 | BRD-K02920722 | BRD-K02920722 | -- | -- | -- | Details |
| C03338 | BRD-K02921955 | BRD-K02921955 | -- | -- | -- | Details |
| C03339 | BRD-K02924457 | SA-97110 | -- | -- | -- | Details |
| C03340 | BRD-K02927581 | BRD-K02927581 | -- | -- | -- | Details |
| C03341 | BRD-K02927989 | BRD-K02927989 | -- | -- | -- | Details |
| C03342 | BRD-K02928994 | BRD-K02928994 | -- | -- | -- | Details |
| C03343 | BRD-K02929561 | BRD-K02929561 | -- | -- | -- | Details |
| C03344 | BRD-K02931142 | BRD-K02931142 | -- | -- | -- | Details |
| C03345 | BRD-K02934881 | BRD-K02934881 | -- | -- | -- | Details |
| C03346 | BRD-K02943813 | dasabuvir | -- | -- | -- | Details |
| C03347 | BRD-K02943940 | BRD-K02943940 | -- | -- | -- | Details |
| C03348 | BRD-K02944060 | BRD-K02944060 | -- | -- | -- | Details |
| C03349 | BRD-K02946901 | BRD-K02946901 | -- | -- | -- | Details |
| C03350 | BRD-K02950022 | BMS-299897 | -- | -- | -- | Details |
| C03351 | BRD-K02952507 | BRD-K02952507 | -- | -- | -- | Details |
| C03352 | BRD-K02953697 | naringin | -- | -- | -- | Details |
| C03353 | BRD-K02953825 | BRD-K02953825 | -- | -- | -- | Details |
| C03354 | BRD-K02959126 | BRD-K02959126 | -- | -- | -- | Details |
| C03355 | BRD-K02960110 | BRD-K02960110 | -- | -- | -- | Details |
| C03356 | BRD-K02964016 | BRD-K02964016 | -- | -- | -- | Details |
| C03357 | BRD-K02965346 | SU-11274 | MET | Tyrosine kinase inhibitor; Hepatocyte growth factor receptor inhibitor | -- | Details |
| C03358 | BRD-K02965577 | secalciferol | VDR | Vitamin D receptor agonist | -- | Details |
| C03359 | BRD-K02969269 | BRD-K02969269 | -- | -- | -- | Details |
| C03360 | BRD-K02971764 | BRD-K02971764 | -- | -- | -- | Details |
| C03361 | BRD-K02972160 | BRD-K02972160 | -- | -- | -- | Details |
| C03362 | BRD-K02979518 | BRD-K02979518 | -- | -- | -- | Details |
| C03363 | BRD-K02985669 | BRD-K02985669 | -- | -- | -- | Details |
| C03364 | BRD-K02986291 | BRD-K02986291 | -- | -- | -- | Details |
| C03365 | BRD-K02987495 | BRD-K02987495 | -- | -- | -- | Details |
| C03366 | BRD-K02987635 | BRD-K02987635 | -- | -- | -- | Details |
| C03367 | BRD-K02990757 | BRD-K02990757 | -- | -- | -- | Details |
| C03368 | BRD-K02992638 | lamivudine | -- | -- | -- | Details |
| C03369 | BRD-K03006541 | BRD-K03006541 | -- | -- | -- | Details |
| C03370 | BRD-K03012696 | cefdinir | -- | -- | -- | Details |
| C03371 | BRD-K03013810 | BRD-K03013810 | -- | -- | -- | Details |
| C03372 | BRD-K03015355 | forskolin | ADCY2 | Adenylyl cyclase activator | -- | Details |
| C03373 | BRD-K03015524 | BRD-K03015524 | -- | -- | -- | Details |
| C03374 | BRD-K03016409 | BRD-K03016409 | -- | -- | -- | Details |
| C03375 | BRD-K03026470 | BRD-K03026470 | -- | -- | -- | Details |
| C03376 | BRD-K03028122 | BRD-K03028122 | -- | -- | -- | Details |
| C03377 | BRD-K03034193 | BRD-K03034193 | -- | -- | -- | Details |
| C03378 | BRD-K03035008 | BRD-K03035008 | -- | -- | -- | Details |
| C03379 | BRD-K03043432 | BRD-K03043432 | -- | -- | -- | Details |
| C03380 | BRD-K03046744 | BRD-K03046744 | -- | -- | -- | Details |
| C03381 | BRD-K03048862 | SA-1939938 | -- | -- | -- | Details |
| C03382 | BRD-K03050455 | BRD-K03050455 | -- | -- | -- | Details |
| C03383 | BRD-K03050720 | BRD-K03050720 | -- | -- | -- | Details |
| C03384 | BRD-K03056434 | BRD-K03056434 | -- | -- | -- | Details |
| C03385 | BRD-K03057797 | BRD-K03057797 | -- | -- | -- | Details |
| C03386 | BRD-K03063480 | PF-477736 | CHEK1 | CHK inhibitor | -- | Details |
| C03387 | BRD-K03067624 | emetine | RPS2 | Protein synthesis inhibitor | -- | Details |
| C03388 | BRD-K03067757 | BRD-K03067757 | -- | -- | -- | Details |
| C03389 | BRD-K03070790 | BRD-K03070790 | -- | -- | -- | Details |
| C03390 | BRD-K03070961 | BRD-K03070961 | -- | -- | arachidonic-acid | Details |
| C03391 | BRD-K03073752 | TUL_XIX003 | -- | -- | TUL-XIX003 | Details |
| C03392 | BRD-K03073795 | SA-1938756 | -- | -- | -- | Details |
| C03393 | BRD-K03077507 | BRD-K03077507 | -- | -- | -- | Details |
| C03394 | BRD-K03079643 | BRD-K03079643 | -- | -- | -- | Details |
| C03395 | BRD-K03088187 | BRD-K03088187 | -- | -- | -- | Details |
| C03396 | BRD-K03089783 | BRD-K03089783 | -- | -- | -- | Details |
| C03397 | BRD-K03090859 | BRD-K03090859 | -- | -- | -- | Details |
| C03398 | BRD-K03093950 | BRD-K03093950 | -- | -- | -- | Details |
| C03399 | BRD-K03095347 | levosimendan | TNNC1 | Calcium sensitizer | -- | Details |
| C03400 | BRD-K03109492 | NSC-663284 | CDC25A; CDC25B | CDC inhibitor | -- | Details |
| C03401 | BRD-K03111155 | BRD-K03111155 | -- | -- | -- | Details |
| C03402 | BRD-K03113036 | BRD-K03113036 | -- | -- | -- | Details |
| C03403 | BRD-K03116010 | BRD-K03116010 | -- | -- | -- | Details |